With volatile market conditions and recent FDA shakeups, biotech companies are increasingly focused on bolstering cash runways and accelerating R&D efforts. But fierce competition for financing has some biotechs turning to...more
7/14/2025
/ Bayh-Dole Act ,
Biotechnology ,
Contract Terms ,
FDA Approval ,
Financing ,
Food and Drug Administration (FDA) ,
Hart-Scott-Rodino Act ,
Healthcare ,
Intellectual Property Protection ,
IP License ,
Life Sciences ,
Market Volatility ,
Ownership of Works ,
Pharmaceutical Industry ,
R&D ,
Research and Development
You put in the hard work to conceive and design your product, choose a trademark, and build your customer following, but taking your product brand to the next level and attracting an equity investment based in large part on...more